Minimally Invasive Surgical Solution in the Treatment of an Unusual Distal Type I Endoleak after Endovascular Abdominal Aortic Aneurysm Repair

Vascular ◽  
2005 ◽  
Vol 13 (06) ◽  
pp. 362
Author(s):  
Adamastor Humberto Pereira ◽  
Luiz Francisco Machado da Costa ◽  
Gilberto Gonçalves de Souza ◽  
Alexandre Araujo Pereira
2004 ◽  
Vol 18 (6) ◽  
pp. 621-628 ◽  
Author(s):  
Sergio M. Sampaio ◽  
Jean M. Panneton ◽  
Geza I. Mozes ◽  
James C. Andrews ◽  
Thomas C. Bower ◽  
...  

EJVES Extra ◽  
2005 ◽  
Vol 10 (5) ◽  
pp. 114-116
Author(s):  
P. Astarci ◽  
S.S. Zhou ◽  
R. McWilliams ◽  
S.D. Blair ◽  
J. Brennan ◽  
...  

2009 ◽  
Vol 79 (11) ◽  
pp. 829-835
Author(s):  
Chris N. Bakoyiannis ◽  
Nikolaos S. Tsekouras ◽  
Sotiris E. Georgopoulos ◽  
Ioanna C. Skrapari ◽  
Konstantinos P. Economopoulos ◽  
...  

2017 ◽  
Vol 51 (1) ◽  
pp. 28-32 ◽  
Author(s):  
Assaf Graif ◽  
Ansar Z. Vance ◽  
Mark J. Garcia ◽  
Kevin T. Lie ◽  
Michael K. McGarry ◽  
...  

Purpose: To evaluate the feasibility, safety, and outcome of transcatheter embolization using ethylene vinyl alcohol copolymer (EVOH) of type I endoleaks associated with endovascular abdominal aortic aneurysm repair. Patient Population and Methods: Retrospective chart review was performed to identify 8 consecutive patients who had undergone EVOH embolization for type I endoleaks between 2012 and 2015. The primary approach used to access the endoleak was the perigraft technique, where the endoleak itself is catheterized at the anastomotic site. Results: Six type Ia and 2 type Ib endoleaks were treated. In 2 patients, a direct transabdominal approach was used to access the endoleak because it was inaccessible via the perigraft approach. Coils were used in addition to EVOH in 5 cases. Residual endoleak was noted in 1 case, whereas 2 patients developed a recurrent type I endoleak during follow-up. No EVOH complications were observed. The 5 remaining patients demonstrated freedom from endoleak and reintervention at a mean follow-up of 6.9 months. Conclusion: Type I endoleaks can be safely and effectively treated by embolotherapy with EVOH. Larger endoleaks resulting from grossly undersized endografts appear to be unsuitable for EVOH embolization.


2008 ◽  
Vol 47 (2) ◽  
pp. 450-453 ◽  
Author(s):  
Russell C. Lam ◽  
Soo J. Rhee ◽  
Nicholas J. Morrissey ◽  
James F. McKinsey ◽  
Peter L. Faries ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document